Catalyst Pharmaceuticals (CPRX)
15.51
+0.17 (1.11%)
Upcoming Events
Latest Headlines
Form 4 CATALYST PHARMACEUTICALS For: Apr 08 Filed by: Tierney David S
April 10, 2024 5:16 PM - SEC Filing
Form ARS CATALYST PHARMACEUTICALS For: Dec 31
April 10, 2024 4:26 PM - SEC Filing
Form DEF 14A CATALYST PHARMACEUTICALS For: May 21
April 10, 2024 4:23 PM - SEC Filing
Form 144 CATALYST PHARMACEUTICALS Filed by: Tierney David S
April 8, 2024 2:03 PM - SEC Filing
Here are Oppenheimer’s best Smidcap ideas
April 2, 2024 10:00 AM - StreetInsider
Form 4 CATALYST PHARMACEUTICALS For: Mar 27 Filed by: Elsbernd Brian
March 28, 2024 4:50 PM - SEC Filing
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
March 28, 2024 8:03 AM - StreetInsider
Form 144 CATALYST PHARMACEUTICALS Filed by: Elsbernd Brian
March 27, 2024 3:02 PM - SEC Filing
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
March 27, 2024 8:03 AM - Globe NewsWire
Citi Starts Catalyst Pharmaceutical Partners (CPRX) at Buy
March 14, 2024 5:06 AM - StreetInsider
Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
March 14, 2024 2:00 AM - StreetInsider
Form 8-K CATALYST PHARMACEUTICALS For: Mar 13
March 13, 2024 5:01 PM - SEC Filing
Catalyst Pharmaceuticals (CPRX) Announces AGAMREE Now Commercially Available in the US
March 13, 2024 7:55 AM - StreetInsider
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
March 13, 2024 7:55 AM - StreetInsider
BofA Securities Starts Catalyst Pharmaceutical Partners (CPRX) at Buy, 'undervalued biotech with key drug launch this year'
March 7, 2024 6:04 AM - StreetInsider
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
March 5, 2024 8:03 AM - Globe NewsWire
Catalyst Pharmaceutical Partners (CPRX) PT Raised to $34 at Cantor Fitzgerald
March 1, 2024 6:33 AM - StreetInsider
Form 8-K CATALYST PHARMACEUTICALS For: Feb 28
February 29, 2024 6:22 AM - SEC Filing
Catalyst Pharmaceuticals (CPRX) Tops Q4 EPS by 26c
February 28, 2024 6:14 PM - StreetInsider
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 28, 2024 6:03 PM - Globe NewsWire
Form 10-K CATALYST PHARMACEUTICALS For: Dec 31
February 28, 2024 5:28 PM - SEC Filing
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated wi
February 27, 2024 8:03 AM - Globe NewsWire
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with A
February 27, 2024 8:03 AM - StreetInsider
Form 8-K CATALYST PHARMACEUTICALS For: Feb 21
February 21, 2024 4:37 PM - SEC Filing
Catalyst Pharmaceuticals (CPRX) Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone Study Results in the Peer-Reviewed Journal Neurology
February 21, 2024 9:00 AM - StreetInsider
Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology
February 21, 2024 9:00 AM - StreetInsider
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Daly Richard J
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: O'Keeffe Charles B
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Miller Steve
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Tierney David S
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Del Carmen Jeffrey
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: DENKHAUS DONALD A
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Sundaram Preethi
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: INGENITO GARY
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Elsbernd Brian
February 16, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 15 Filed by: Harper Molly
February 16, 2024 5:01 PM - SEC Filing
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
February 14, 2024 8:03 AM - StreetInsider
Form SC 13G/A CATALYST PHARMACEUTICALS Filed by: VANGUARD GROUP INC
February 13, 2024 5:03 PM - SEC Filing
Form SC 13G/A CATALYST PHARMACEUTICALS Filed by: Flynn James E
February 12, 2024 5:32 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Feb 05 Filed by: DENKHAUS DONALD A
February 6, 2024 5:01 PM - SEC Filing
Form 4 CATALYST PHARMACEUTICALS For: Jan 30 Filed by: MCENANY PATRICK J
January 31, 2024 5:02 PM - SEC Filing
Form SC 13G/A CATALYST PHARMACEUTICALS Filed by: STATE STREET CORP
January 25, 2024 10:09 AM - SEC Filing
Form SC 13G/A CATALYST PHARMACEUTICALS Filed by: BlackRock Inc.
January 22, 2024 3:53 PM - SEC Filing
Full Article List
